ARS Pharmaceuticals, Inc. (SPRY)
Market Cap | 839.11M |
Revenue (ttm) | 10,000 |
Net Income (ttm) | -49.70M |
Shares Out | 96.90M |
EPS (ttm) | -0.52 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 547,997 |
Open | 8.66 |
Previous Close | 8.73 |
Day's Range | 8.65 - 9.14 |
52-Week Range | 2.55 - 11.27 |
Beta | n/a |
Analysts | Buy |
Price Target | 18.50 (+113.63%) |
Earnings Date | Aug 8, 2024 |
About SPRY
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California. [Read more]
Financial Performance
In 2023, SPRY's revenue was $30,000, a decrease of -97.72% compared to the previous year's $1.32 million. Losses were -$54.37 million, 56.8% more than in 2022.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for SPRY stock is "Buy." The 12-month stock price forecast is $18.5, which is an increase of 113.63% from the latest price.
News
![](https://cdn.snapi.dev/images/v1/p/i/press3-2507333.jpg)
Probe Into Claims Against ARS Pharmaceuticals Inc Initiated By The Schall Law Firm And Impacted Investors Are Encouraged To Participate
LOS ANGELES, CA / ACCESSWIRE / July 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/i/r/press7-2502237.jpg)
The Schall Law Firm Initiates Probe Into Claims Against ARS Pharmaceuticals Inc And Urges Affected Investors To Participate
LOS ANGELES, CA / ACCESSWIRE / June 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/v/y/press17-2501467.jpg)
ARS Pharmaceuticals Announces EURneffy (adrenaline nasal spray) Recommended for Approval by CHMP for Emergency Treatment of Allergic Reactions (anaphylaxis)
EURneffy positioned to be the first and only needle-free adrenaline option authorized for emergency treatment of allergic reactions (anaphylaxis) in Europe
![](https://cdn.snapi.dev/images/v1/p/k/press1-2498974.jpg)
The Schall Law Firm Begins Investigation Into Allegations Against ARS Pharmaceuticals Inc And Encourages Impacted Investors To Get Involved
LOS ANGELES, CA / ACCESSWIRE / June 26, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/q/b/press13-2496080.jpg)
The Schall Law Firm Begins Investigation Into Allegations Against ARS Pharmaceuticals Inc And Encourages Impacted Investors To Join
LOS ANGELES, CA / ACCESSWIRE / June 25, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/i/j/press2-2491888.jpg)
The Schall Law Firm Starts Investigation Into Allegations Against ARS Pharmaceuticals Inc And Encourages Impacted Investors To Get Involved
LOS ANGELES, CA / ACCESSWIRE / June 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/e/d/press6-2491460.jpg)
The Schall Law Firm Begins Probe Into Claims Against ARS Pharmaceuticals Inc And Urges Affected Investors To Participate
LOS ANGELES, CA / ACCESSWIRE / June 22, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/s/l/press10-2491049.jpg)
The Schall Law Firm Initiates Investigation Into Allegations Against ARS Pharmaceuticals Inc And Encourages Impacted Investors To Get Involved
LOS ANGELES, CA / ACCESSWIRE / June 21, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/k/d/press16-2487018.jpg)
Allegations Against ARS Pharmaceuticals Inc Schall Law Firm Initiates Investigation And Encourages Impacted Investors To Get Involved
LOS ANGELES, CA / ACCESSWIRE / June 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/w/k/press12-2485613.jpg)
Allegations Against ARS Pharmaceuticals Inc The Schall Law Firm Initiates Investigation And Encourages Impacted Investors To Get Involved
LOS ANGELES, CA / ACCESSWIRE / June 18, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/1/z/press13-2483412.jpg)
Claims Against Ars Pharmaceuticals Inc Schall Law Firm Begins Probe And Urges Affected Investors To Participate
LOS ANGELES, CA / ACCESSWIRE / June 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/s/l/press16-2474572.jpg)
Allegations Against ARS Pharmaceuticals, Inc.: Schall Law Firm Initiates Investigation And Encourages Impacted Investors To Get Involved
LOS ANGELES, CA / ACCESSWIRE / June 11, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutica...
![](https://cdn.snapi.dev/images/v1/a/p/press14-2470222.jpg)
Charges Against ARS Pharmaceuticals, Inc.: Schall Law Firm Launches Examination And Invites Affected Investors To Participate
LOS ANGELES, CA / ACCESSWIRE / June 9, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/u/m/press19-2469768.jpg)
Accusations Against ARS Pharmaceuticals, Inc.: Schall Law Firm Initiates Inquiry And Calls On Impacted Investors To Engage
LOS ANGELES, CA / ACCESSWIRE / June 8, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/e/x/press7-2469261.jpg)
Claims Against ARS Pharmaceuticals, Inc.: Schall Law Firm Begins Probe And Invites Affected Investors To Connect
LOS ANGELES, CA / ACCESSWIRE / June 7, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/3/u/press4-2466886.jpg)
Allegations Against ARS Pharmaceuticals, Inc.: Schall Law Firm Initiates Investigation And Encourages Impacted Investors To Reach Out
LOS ANGELES, CA / ACCESSWIRE / June 6, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/n/l/press4-2464529.jpg)
ARS Pharmaceuticals, Inc. Allegations: Schall Law Firm Commences Examination and Calls on Affected Investors to Connect
LOS ANGELES, CA / ACCESSWIRE / June 5, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/x/4/press10-2462376.jpg)
The Schall Law Firm is commencing an examination into allegations against ARS Pharmaceuticals, Inc. and is calling on investors who have experienced losses to get in touch
LOS ANGELES, CA / ACCESSWIRE / June 4, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/e/h/press15-2460404.jpg)
SPRY INVESTIGATION PROGRESS REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 3, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/i/s/press3-2458058.jpg)
IMPORTANT INVESTIGATION UPDATE: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 2, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/a/y/press3-2457610.jpg)
IMPORTANT INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 1, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/m/c/press7-2457202.jpg)
IMPORTANT INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 31, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/w/e/press7-2454686.jpg)
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 30, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/h/h/press20-2438797.jpg)
IMPORTANT INVESTOR ALERT: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 19, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...
![](https://cdn.snapi.dev/images/v1/c/x/press8-2437748.jpg)
IMPORTANT SHAREHOLDER INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against ARS Pharmaceuticals, Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of ARS Pharmaceutical...